A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors

Press/Media

Period	18 Jun 2019

Media coverage

Title	A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
Media name/outlet	The Oncologist
Country/Territory	United States
Date	18/06/19
URL	theoncologist.alphamedpress.org/content/24/6/857.short?rss=1
Persons	Gary Schwartz